Spero Therapeutics, Inc. SPRO
Set alert
1.06 USD -0.05 -4.50%
At close · Oct 30
1.08 +0.02 +1.84%
After hours · Oct 30, 5:47 PM ET
1.05 Day range 1.12
1.06 52-week range 2.98
- YTD
- -54.51%
- 1 year
- -55.08%
- Open
- 1.11
- Prev close
- 1.11
- Mkt cap
- 61.73M
- Vol
- 309.87K
- Avg vol
- 608.55K
- EPS
- 0.14
- P/E
- 7.57
- Div yield
- 0.00%
More statistics
- Low
- 1.05
- High
- 1.12
- Forward P/E
- -0.83
- Beta
- 0.63
- Short ratio
- 2.08
- Inst. own
- 23.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 1.20
- 200-d avg
- 1.38
- 1y target
- 5.00
Financial health
Altman Z-Score
-5.81 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 1
- Return on Equity 4
- Return on Assets 5
- Debt / Equity 4
- P/E 3
- P/B 2
Valuation
P/E 15.5×
FY 2016 5y median -0.8× FY 2025
P/S 2.2×
FY 2016 5y median 1.3× FY 2025
P/B 2.2×
FY 2016 5y median 1.2× FY 2025
P/FCF -10.3×
FY 2016 5y median -7.7× FY 2025
EV/EBITDA 10.5×
FY 2016 5y median 0.2× FY 2025
EV/Sales 1.6×
FY 2016 5y median 0.1× FY 2025
FCF Yield -9.7%
FY 2016 5y median -13.0% FY 2025
Profitability
Gross Margin 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -0.0%
FY 2016 5y median -86.9% FY 2025
Net Margin 14.4%
FY 2016 5y median -95.5% FY 2025
ROE 14.5%
FY 2016 5y median -61.1% FY 2025
ROIC -0.0%
FY 2016 5y median -40.2% FY 2025
ROA 12.4%
FY 2016 5y median -37.2% FY 2025
Growth (YoY)
Revenue 24.3%
FY 2016 FY 2025
Operating Income 100.0%
FY 2016 FY 2025
EPS (diluted) 111.8%
FY 2016 FY 2025
Free Cash Flow 46.2%
FY 2016 FY 2025
Financial Health
Current Ratio 7.6×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 7.6×
FY 2016 5y median 5.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -4.2×
FY 2016 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31